Breakthrough Biologics: Charting the Course for Sjögren's Syndrome Treatment in 2024.
Saved in:
| Title: | Breakthrough Biologics: Charting the Course for Sjögren's Syndrome Treatment in 2024. |
|---|---|
| Authors: | Hsu TC; Department of Allergy, Immunology and Rheumatology, Wuri Lin Shin Hospital, Taichung, Taiwan.; College of Health Care and Management, Chung Shan Medical University, Taichung, Taiwan., Wei JC; Department of Nursing, Chung Shan Medical University, Taichung, Taiwan.; Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan. |
| Source: | International journal of rheumatic diseases [Int J Rheum Dis] 2026 Apr; Vol. 29 (4), pp. e70650. |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model: Print Cited Medium: Internet ISSN: 1756-185X (Electronic) Linking ISSN: 17561841 NLM ISO Abbreviation: Int J Rheum Dis Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 1756-185X |
|---|---|
| DOI: | 10.1111/1756-185x.70650 |
